Search

everythinglearnresearchcommunity

for

Search:↓

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

Ingenol mebutate gel changes gene expression related to skin development and immune response in actinic keratosis.

CD2 might be a new treatment target for patchy alopecia areata.

Hair loss treatment caused more hair loss in a man.

Astragalus membranaceus helps regrow hair and reduce hair loss symptoms.

The skin protects the body, regulates temperature, senses touch, and makes vitamin D.

A patient with total hair loss developed vitiligo after using a treatment called DCP.

Pediatric transplant patients often experience unique skin changes mainly due to medication use.

Crohn's disease can cause hair loss before other symptoms appear.

New treatments for skin diseases are more effective and patient-friendly, but many still lack a cure.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

IMA and IMA/albumin levels don't predict alopecia areata severity.

The mesenchymal stem cell-conditioned medium gel improved burn healing and hair growth in rats better than other treatments.

Dupilumab can improve both atopic dermatitis and alopecia universalis.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

A boy with severe immune deficiency and Epstein-Barr virus died from high-grade B-cell lymphoma.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Peanut allergies can be transferred through organ transplants.

The index to ring finger ratio may indicate disease severity in female ankylosing spondylitis patients, but not in males.

Animal models, especially mice, are essential for advancing hair loss research and treatment.

A girl with Crohn's disease developed hair loss from her medication, which improved with treatment but later returned.

Different stem cells have benefits and challenges for tissue repair, and more research is needed to find the best types for each use.

The document concludes that skin grafts are essential for repairing tissue loss, with various types available and ongoing research into substitutes to improve outcomes and reduce donor site issues.

Treatments for autoimmune hair loss have limited success and often relapse, and emotional support is crucial for those affected.

Immunization and throat bacteria may increase the risk of a hair loss condition called alopecia areata.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

Some alternative therapies for vitiligo show promise but need more research.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.

AB+ blood group is more common in alopecia areata patients.